TABLE 1.
Plasma BDG levels in pediatric patients with or without candidemia
| Patient | No. of patients | BDG level (pg/ml) (median [range]) | P | Sensitivity (%) | Specificity (%) |
|---|---|---|---|---|---|
| Candidemiaa | |||||
| Age, ≤28 days | 8 | 0.024b | |||
| C. albicans | 3 | 3,378.0 (1,797.0–3,895.0) | 100 | 91 | |
| C. parapsilosis | 5 | 41.4 (<10.0–74.3) | 60 | 91 | |
| Age, >28 days to 12 years | 48 | 0.029b | |||
| C. albicans | 7 | 453.0.4 (14.8–3,434.0) | 100 | 91 | |
| C. guilliermondii | 12 | 139.1 (<10.0–636.0) | 83 | 91 | |
| C. parapsilosis | 17 | 70.8 (<10.0–983.3) | 65 | 91 | |
| C. famata | 10 | <10.0 (<10.0–498.1) | 30 | 91 | |
| C. albicans and C. parapsilosis | 1 | <10.0 | |||
| C. lusitaniae | 1 | 18.9 | |||
| Subtotal | 56 | 73.5 (<10.0–3,895.0) | 0.001c | 68 | 91 |
| Noncandidemia | 210 | <10.0 (<10.0–1,000.0) |
a
Candidemia cases were divided with each age subgroup based on the different causal Candida species.
b
Plasma BDG levels were statistically different among candidemia cases caused by different Candida species.
c
The median (range) value of plasma BDG in the 56 patients with candidemia was significantly higher than that in 210 patients without candidemia.